Press release
Oral Biologics And Biosimilars Market 2020 Global Analysis, Trends, Forecast up to 2030 | Merck & Co, GlaxoSmithKline, Novo Nordisk, ALK-Abello A/S, Aimmune Therapeutics, Inc.
Oral Biologics And Biosimilars Market
The global oral biologics and biosimilars market reached a value of nearly $3,076.1 million in 2019, having grown at a compound annual growth rate (CAGR) of 6.5% since 2015, and is expected to grow at a CAGR of 17.1% to nearly $5,787.9 million by 2023. Also, the market is expected to growth to $8,687.7 million in 2025 at a CAGR of 22.5% and to $23,585.5 million in 2030 at a CAGR of 22.1%.
The key drivers of the oral biologics & biosimilars market include:
Technological Advances:
Technology is expected to be a continued driver of market growth during this period. An area of particular development is likely to be physiology simulation modeling. Markets such as this one will benefit from the greater efficiencies offered by developments in this area. For example, Eli Lilly and Pfizer have adopted Amazon’s Elastic Compute Cloud (EC2) platform to conduct simulation models in early drug discovery that have been operational within hours, whereas traditional models would have taken weeks to conduct simulations. The Open Innovation Drug Discovery program is another initiative by Lilly to enhance the research and development of biologics.
Browse Complete Report @ https://www.thebusinessresearchcompany.com/report/oral-biologics-and-biosimilars-market
Oral Biologics & Biosimilars Market Segmentation:
The oral biologics & biosimilars market is segmented by therapeutic mechanism, disease, molecule type, distribution channel and by geography.?
By Therapeutic Mechanism - The oral biologics & biosimilars market can be segmented by therapeutic mechanism
a. Tumor Necrosis Factor-Alpha Inhibitors
b. Lymphocyte Modulators
c. Interleukin Inhibitors
d. GPCR (insulin, growth hormone, parathyroid hormone) Modulators
e. Immunostimulants
f. Others
The others (Interferons, Opioid receptors, Calcitonin receptor) was the largest segment of the oral biologics and biosimilars market by therapeutic mechanism, accounting for $676.1 million of the total market in 2019.
By Disease – The oral biologics & biosimilars market can be segmented by disease
a. Diabetes
b. Arthritis & Chron`s Disease
c. Cancer
d. Infectious Diseases
e. Other Autoimmune Diseases
f. Others Diseases
The infectious diseases was the largest segment of the oral biologics and biosimilars market by disease, accounting for $2,305.6 million or 74.9% of the total market in 2019 and this market is expected to grow at a CAGR of 7.1% during 2019-2023. The diabetes market is expected to be the fastest-growing segment going forward at a CAGR of 82.6%.
Request For A Sample Copy Of This Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=3361&type=smp
By Geography - The oral biologics & biosimilars market is segmented into
1.North America
2.Western Europe
3.Asia Pacific
4.Eastern Europe
5.South America
6.Middle East
7.Africa
Some of the major key players involved in oral biologics & biosimilars market are
• Merck & Co
• GlaxoSmithKline
• Novo Nordisk
• ALK-Abello A/S
• Aimmune Therapeutics, Inc.
Place a DIRECT PURCHASE ORDER of entire 300+ pages report @ https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3361
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on Blog: http://blog.tbrc.info/
About US:
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets after WHO declared COVID-19 as a pandemic.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Oral Biologics And Biosimilars Market 2020 Global Analysis, Trends, Forecast up to 2030 | Merck & Co, GlaxoSmithKline, Novo Nordisk, ALK-Abello A/S, Aimmune Therapeutics, Inc. here
News-ID: 2128907 • Views: …
More Releases from The Business research company
Global Explosives Market 2024-2033: Size, Share & Analysis Forecast
The explosives market size has grown strongly in recent years. It will grow from $48.62 billion in 2023 to $53.2 billion in 2024 at a compound annual growth rate (CAGR) of 9.4%. The growth in the historic period can be attributed to increasing military expenditure, low interest rates, an increase in demand for natural stones and government initiatives towards the mining industry.
The explosives market size is expected to…
Global Egg Market 2024-2033: Growth Trends, Forecast & Competitive Landscape
The egg market size has grown strongly in recent years. It will grow from $269.48 billion in 2023 to $289.9 billion in 2024 at a compound annual growth rate (CAGR) of 7.6%. The growth in the historic period can be attributed to surge in demand for confectionery and bakery products, rise in awareness about health and fitness, and rise in disposable income..
The egg market size is expected to…
Dehumidifiers Market 2024-2033: Trends, Analysis & Growth Forecast
The dehumidifiers market size has grown strongly in recent years. It will grow from $4.42 billion in 2023 to $4.71 billion in 2024 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to rise in disposable income and an increase in the construction of shopping malls.
The dehumidifiers market size is expected to see strong growth in the next few…
Construction Machinery Market 2024-2033: Size, Share & Competitive Landscape
The construction machinery market size has grown strongly in recent years. It will grow from $312.39 billion in 2023 to $341.15 billion in 2024 at a compound annual growth rate (CAGR) of 9.2%. The growth in the historic period can be attributed to strong economic growth in emerging markets, the low interest rate environment, and the supportive government initiatives.
The construction machinery market size is expected to see strong…
More Releases for Disease
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Gaucher Disease Treatment Market, by Disease Type, Therapy Type
Gaucher disease is an autosomal recessive inherited metabolism disorder where a type of fat (lipid) called glucocerebroside is unable to degrade. Body synthesis enzyme called glucocerebrosidase, which breakdowns and reprocesses glucocerebroside. Gaucher disease is caused by mutations of a single gene called GBA, which leads to very low levels of glucocerebrosidase enzyme leading to low degradation of glucocerebroside. There are three types of Gaucher disease namely: type 1, type 2,…
Autoimmune Disease Diagnostic Market By Disease, Tests Type, Regions, Companies
"The Latest Research Report Autoimmune Disease Diagnostic Market, Global Forecast, By Disease, Tests Type, Regions, Companies provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
Autoimmune Disease Diagnostic Market is anticipated to exceed US$ 18 Billion, experiencing a significant growth over the forecast period. Autoimmune diseases take place when there is disruption of the usual control process (immune system of the body becomes…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
